WILLIAM OLIVA: Open Payments
NPI 1356781199 · SPENCER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 31 payments from 11 companies in 2025. Trend: 2023 $408 · 2024 $612 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $148 |
| Janssen Pharmaceuticals, Inc | 4 | $72 |
| Tris Pharma Inc | 4 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| Noven Therapeutics, LLC | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
Products named: CAPLYTA, INVEGA SUSTENNA, Dyanavel XR, FANAPT, REXULTI, UZEDY, VRAYLAR, Xelstrym.
Industry payments across OK — which companies pay providers there.
